Correlation Between China Asset and HOB Biotech

Can any of the company-specific risk be diversified away by investing in both China Asset and HOB Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining China Asset and HOB Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between China Asset Management and HOB Biotech Group, you can compare the effects of market volatilities on China Asset and HOB Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in China Asset with a short position of HOB Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of China Asset and HOB Biotech.

Diversification Opportunities for China Asset and HOB Biotech

-0.7

Correlation Coefficient

China Asset  HOB Biotech

Excellent diversification

The 3 months correlation between China and HOB is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding China Asset Management and HOB Biotech Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HOB Biotech Group and China Asset is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on China Asset Management are associated (or correlated) with HOB Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HOB Biotech Group has no effect on the direction of China Asset i.e., China Asset and HOB Biotech go up and down completely randomly.

Pair Corralation between China Asset and HOB Biotech

Assuming the 90 days trading horizon China Asset Management is expected to generate 0.33 times more return on investment than HOB Biotech. However, China Asset Management is 3.04 times less risky than HOB Biotech. It trades about 0.13 of its potential returns per unit of risk. HOB Biotech Group is currently generating about -0.02 per unit of risk. If you would invest  351.00  in China Asset Management on December 23, 2024 and sell it today you would earn a total of  32.00  from holding China Asset Management or generate 9.12% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

China Asset Management  vs.  HOB Biotech Group

China Asset Management

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in China Asset Management are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, China Asset may actually be approaching a critical reversion point that can send shares even higher in April 2025.

HOB Biotech Group

Risk-Adjusted Performance

Very Weak

Over the last 90 days HOB Biotech Group has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, HOB Biotech is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with China Asset and HOB Biotech

The main advantage of trading using opposite China Asset and HOB Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if China Asset position performs unexpectedly, HOB Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HOB Biotech will offset losses from the drop in HOB Biotech's long position.

The idea behind China Asset Management and HOB Biotech Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.